Friend or Foe? Eosinophilic Granulomatosis with Polyangiitis (EGPA) Onset After Dupilumab: Report of Two Cases and a Narrative Review of the Literature
<b>Background/Objectives</b>: Dupilumab is a fully human IgG4 monoclonal antibody targeting the interleukin-4 receptor α subunit, inhibiting interleukin-4 and interleukin-13 signalling, and suppressing type 2 inflammation. It is approved for several eosinophilic and type 2 inflammatory diseases, inc...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2026-04-01
|
| シリーズ: | Rheumato |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2674-0621/6/2/10 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|